Similar articles

• Scientific opinion on the carcinogenic risk due to topical administration of benzoylperoxide for the treatment of acne vulgaris.

  Zbinden G. Zbinden G. Pharmacol Toxicol. 1988 Nov;63(5):307-9. doi: 10.1111/j.1600-0773.1988.tb00959.x. Pharmacol Toxicol. 1988. PMID: 2976935 No abstract available.
• Malignant melanoma, benzoyl peroxide and acne: a pilot epidemiological case-control investigation.

  Cartwright RA, Hughes BR, Cunliffe WJ. Cartwright RA, et al. Br J Dermatol. 1988 Feb;118(2):239-42. doi: 10.1111/j.1365-2133.1988.tb01780.x. Br J Dermatol. 1988. PMID: 2964857
• Is benzoyl peroxide carcinogenic.

  Lidén S, Lindelöf B, Sparén P. Lidén S, et al. Br J Dermatol. 1990 Jul;123(1):129-30. doi: 10.1111/j.1365-2133.1990.tb01836.x. Br J Dermatol. 1990. PMID: 2143946 No abstract available.
• Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.

  Keating GM. Keating GM. Am J Clin Dermatol. 2011 Dec 1;12(6):407-20. doi: 10.2165/11208170-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967116 Review.
• Reticulate hyperpigmentation of the skin after topical application of benzoyl peroxide.

  Weinberg JM, Moss T, Gupta SM, White SM, Don PC. Weinberg JM, et al. Acta Derm Venereol. 1998 Jul;78(4):301-2. doi: 10.1080/000155598441954. Acta Derm Venereol. 1998. PMID: 9689304 Review. No abstract available.